Medicines Company prez, COO resigns
Justine Varieur Cadet | October 07, 2009 | Cardiovascular Business | Interventional Cardiology
John P. Kelley has resigned as The Medicines Company’s president and chief operating officer (COO).

Kelley resigned from these positions, and as director of the company to pursue other interests, effective Oct. 1, 2009. According to the Parsippany, N.J.-based company, Kelley will serve as a special advisor to its chief executive officer until  Dec. 31 or until he commences other full-time employment.

Justine Varieur Cadet

Related Content

Cardiologists make history, perform first-ever transcaval TAVR for pure aortic regurgitation
Q&A: Interventional cardiologist details key breakthroughs in tricuspid valve replacement and repair
Boston Scientific recalls premixed embolic agent after two deaths
New cardiac imaging strategy could reduce ICA, PCI rates
Inter-atrial shunt in RELIEVE-HF improves symptoms in HFrEF, but not HFpEF
FDA grants new imaging tool for CTO interventions its breakthrough device designation

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Radiology Business
Philips launches new AI-enabled CT scanner aimed at cardiology at ECR 2024

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Design by Adaptive Theme
Trimed Popup
Trimed Popup